NM_000141.5:c.1611G>C
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP2
The NM_000141.5(FGFR2):c.1611G>C(p.Met537Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 33) 
Consequence
 FGFR2
NM_000141.5 missense
NM_000141.5 missense
Scores
 6
 11
 2
Clinical Significance
Conservation
 PhyloP100:  7.90  
Publications
43 publications found 
Genes affected
 FGFR2  (HGNC:3689):  (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009] 
FGFR2 Gene-Disease associations (from GenCC):
- Apert syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- Beare-Stevenson cutis gyrata syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Genomics England PanelApp
- Crouzon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, PanelApp Australia, Genomics England PanelApp, G2P
- Jackson-Weiss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- LADD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Pfeiffer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- bent bone dysplasia syndrome 1Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- familial scaphocephaly syndrome, McGillivray typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Saethre-Chotzen syndromeInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- Antley-Bixler syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- LADD syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
PP2
Missense variant in the FGFR2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 114 curated pathogenic missense variants (we use a threshold of 10). The gene has 24 curated benign missense variants. Gene score misZ: 2.402 (below the threshold of 3.09). Trascript score misZ: 4.4365 (above the threshold of 3.09). GenCC associations: The gene is linked to Pfeiffer syndrome type 3, Crouzon syndrome, Apert syndrome, Antley-Bixler syndrome, Beare-Stevenson cutis gyrata syndrome, Jackson-Weiss syndrome, bent bone dysplasia syndrome 1, Pfeiffer syndrome, Saethre-Chotzen syndrome, LADD syndrome 1, familial scaphocephaly syndrome, McGillivray type, LADD syndrome, Pfeiffer syndrome type 1, Pfeiffer syndrome type 2, Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR2 | ENST00000358487.10 | c.1611G>C | p.Met537Ile | missense_variant | Exon 12 of 18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
| FGFR2 | ENST00000457416.7 | c.1614G>C | p.Met538Ile | missense_variant | Exon 12 of 18 | 1 | ENSP00000410294.2 | |||
| FGFR2 | ENST00000369056.5 | c.1614G>C | p.Met538Ile | missense_variant | Exon 11 of 17 | 1 | ENSP00000358052.1 | |||
| FGFR2 | ENST00000369058.7 | c.1614G>C | p.Met538Ile | missense_variant | Exon 12 of 17 | 1 | ENSP00000358054.3 | |||
| FGFR2 | ENST00000613048.4 | c.1344G>C | p.Met448Ile | missense_variant | Exon 11 of 17 | 5 | ENSP00000484154.1 | |||
| FGFR2 | ENST00000369061.8 | c.1275G>C | p.Met425Ile | missense_variant | Exon 9 of 15 | 1 | ENSP00000358057.4 | |||
| FGFR2 | ENST00000369059.5 | c.1269G>C | p.Met423Ile | missense_variant | Exon 10 of 16 | 5 | ENSP00000358055.1 | |||
| FGFR2 | ENST00000360144.7 | c.1347G>C | p.Met449Ile | missense_variant | Exon 11 of 17 | 2 | ENSP00000353262.3 | |||
| FGFR2 | ENST00000478859.5 | c.927G>C | p.Met309Ile | missense_variant | Exon 11 of 17 | 1 | ENSP00000474011.1 | |||
| FGFR2 | ENST00000429361.5 | c.387G>C | p.Met129Ile | missense_variant | Exon 4 of 9 | 5 | ENSP00000404219.1 | |||
| FGFR2 | ENST00000604236.5 | n.*658G>C | non_coding_transcript_exon_variant | Exon 11 of 17 | 1 | ENSP00000474109.1 | ||||
| FGFR2 | ENST00000604236.5 | n.*658G>C | 3_prime_UTR_variant | Exon 11 of 17 | 1 | ENSP00000474109.1 | 
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
33
GnomAD4 exome Cov.: 31 
GnomAD4 exome 
Cov.: 
31
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
33
ClinVar
Significance: Likely pathogenic 
Submissions summary: Pathogenic:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation    Pathogenic:1 
Dec 26, 2014
Database of Curated Mutations (DoCM)
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Uncertain 
 DEOGEN2 
 Pathogenic 
.;.;.;D;.;.;.;D;D;.;T;.;.;.;.;. 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D 
 M_CAP 
 Uncertain 
D 
 MetaRNN 
 Uncertain 
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D 
 MetaSVM 
 Uncertain 
D 
 MutationAssessor 
 Benign 
.;.;.;N;.;.;.;.;.;.;.;.;.;.;.;. 
 PhyloP100 
 PrimateAI 
 Pathogenic 
D 
 PROVEAN 
 Uncertain 
D;D;.;D;.;D;N;D;D;D;.;D;D;D;D;D 
 REVEL 
 Pathogenic 
 Sift 
 Uncertain 
D;D;.;D;.;D;D;D;D;D;.;D;D;D;D;D 
 Sift4G 
 Uncertain 
D;T;T;D;T;T;T;T;T;D;D;D;T;D;D;. 
 Polyphen 
 0.92, 0.99, 1.0, 0.43, 0.99 
.;P;.;D;.;D;.;.;.;.;.;.;B;D;.;. 
 Vest4 
 MutPred 
 0.43 
.;.;.;Loss of disorder (P = 0.0556);.;.;.;.;.;.;Loss of disorder (P = 0.0556);.;.;.;.;.;
 MVP 
 MPC 
 1.9 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.